CVS vs UNH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CVS · CVS Health$83.85 ▲ 3.10%
UNH · UnitedHealth$394.15 ▼ 0.40%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CVS +10.7%
- UNH +25.1%
Head to head
| Metric | CVS | UNH |
|---|---|---|
| Price | $83.85 | $394.15 |
| Change today | ▲ 3.10% | ▼ 0.40% |
| Market cap | $107.28B | $353.17B |
| Return, 3 months | -12.4% | -3.6% |
| Return, year to date | +8.1% | +21.0% |
| Return, 1 year | +8.6% | +24.0% |
| P/E (TTM) | 9.7 | 22.5 |
| P/B | 1.3 | 3.6 |
| P/E percentile vs own 5y | 67th | 40th |
| Dividend yield | 3.17% | 2.30% |
| Revenue growth (YoY, latest qtr) | +7.3% | -0.4% |
| Net profit growth (YoY) | +195.7% | +69.1% |
| Gross margin | 14.2% | 19.8% |
| Operating margin | 3.4% | 5.3% |
| Net margin | 1.2% | 3.5% |
| Return on equity | 6.2% | 15.9% |
| Analyst target vs. price | +32.7% | +22.5% |
| Analyst buy share | 100% | 82% |
| RSI (14) | 40 | 46 |
| 30-day volatility | 47.4% | 27.8% |
| Max drawdown, 1 year | -27.3% | -28.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UNH is the largest of the group by market value.
- UNH has returned the most over the past year.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS is growing revenue fastest.
- UNH keeps the most profit per dollar of sales.
- UNH has been the calmest stock over the last 30 days.